Krystal Biotech FY2026 EPS Forecast Boosted by HC Wainwright
Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) – Stock analysts at HC Wainwright upped their FY2026 earnings per share (EPS) estimates for Krystal Biotech in a research note issued on Monday, April 28th. HC Wainwright analyst J. Pantginis now anticipates that the company will post earnings per share of $6.30 for the year, up from […]
